Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures

Life Sciences

Volumn 78, Issue 22, 2006, Pages 2571-2576

  Üzüm, Gülay ^a   Sarper Diler, A ^a   Bahçekapili, Nesrin ^a   Ziya Ziylan, Y ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Erythropoietin; Pentylentetrazol; Seizures

Indexed keywords

EVANS BLUE; PENTETRAZOLE; RECOMBINANT ERYTHROPOIETIN; ANTIANEMIC AGENT; CONVULSANT AGENT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EVALUATION; HIPPOCAMPUS; LATENT PERIOD; MALE; MESENCEPHALON; NONHUMAN; RAT; SEIZURE; SPECTROPHOTOMETRY; STAINING; THALAMUS; TONIC CLONIC SEIZURE; ANIMAL; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REACTION TIME; WISTAR RAT;

ANIMALS; BLOOD-BRAIN BARRIER; CAPILLARY PERMEABILITY; CONVULSANTS; DISEASE MODELS, ANIMAL; DRUG ANTAGONISM; ERYTHROPOIETIN, RECOMBINANT; HEMATINICS; INJECTIONS, INTRAPERITONEAL; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; REACTION TIME; SEIZURES;

EID: 33646705396     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.10.027     Document Type: Article

References (34)

1. Ateş N., Uzum G., Diler A.S., and Ziylan Y.Z. The cerebrovascular permeability and epilepsy; the role of blood pressure. Neuroscience Research Communication 10 (1992) 163-169
2. Banerjee D., Rodriguez M., Nag M., and Adamson J.W. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney International 57 (2000) 1895-1904
3. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri L.M., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 10526-10531
4. Buemi M., Cavallaro E., Floccari F., Sturi{dotless}ale A., Aloisi C., Trimarchi M., Grasso G., and Corica F. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clinical Science 103 (2002) 275-282
5. Cerami A., Brines M.L., Ghezzi P., and Cerami C.J. Effects of EPOetin alfa on the central nervous system. Seminars in Oncology 45 (2001) 7-14
6. Chikuma M., Masuda S., Kobayashi T., Nagao M., and Sasaki R. Tissue-specific regulation of erythropoietin production in the murine kidney, brain and uterus. American Journal of Physiology: Endocrinology and Metabolism 279 (2000) E1242-E1248
7. Dame C., Juul S.E., and Christensen R.D. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate 79 (2001) 228-235
8. The blood brain-barrier. In: Davson H., and Segal M.B. (Eds). Physiology of the CSF and of the Blood-rain Barrier (1995), CRC, New York 49-91
9. Digicayli{dotless}oglu M., Bichet S., Marti H.H., Wenger R.H., Rivas L.A., Bauer C., and Gassmann M. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 3717-3720
10. Grant G.A., Abbott N.J., and Janigro D. Understanding the physiology of blood-brain barrier: in vitro models. News in Physiological Sciences 13 6 (1998) 287-293
11. Grasso G., Buemi M., Alafaci C., Sfacteria A., Passalacqua M., Sturiale A., Calapai G., De Vico G., Piedimonte G., Salpietro F.M., and Tomasello F. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbit subjected to subarachnoid hemorrhage. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 5627-5631
12. Hendryk S., Jedrzejowska-Szypulka H., Josko J., Jarzab B., and Döhler K.D. Influence of the corticotrophin releasing hormone (CRH) on the brain blood barrier permeability in cerebral ischemia in rats. Journal of Physiology and Pharmacology 53 (2002) 85-94
13. Homayoun H., Khavandgar S., and Dehpour A.R. Anticonvulsant effects of cyclosporin A on pentylentetrazol-induced seizure and kindling: modulation by nitricoxidergic system. Brain Research 939 (2002) 1-10
14. Jayakumar A.R., Sujatha R., Paul V., Asokan C., Govindasamy S., and Jayakumar R. Role of nitric oxide on GABA, glutamic acid, activities of GABA-T and GAD in rat brain cerebral cortex. Brain Research 837 (1999) 229-235
15. Kamisaki Y., Wada K., Nakamoto K., and Itoh T. Nitric oxide inhibition of the depolarization evoked glutamate release from synaptosomes of rat cerebellum. Neuroscience Letter 194 (1995) 5-8
16. Koshimura K., Murakami Y., Sohmiya M., Tanaka J., and Kato Y. Effect of erythropoietin on neuronal activity. Journal of Neurochemistry 72 (1999) 2565-2572
17. Marti H.H., Gassman M., Wenger R.H., et al. Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney International 51 (1997) 416-418
18. Martinez-Estrada O.M., Rodriguez-Millan E., Gonzalez-de Vicente E., Reina M., Vilaro S., and Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. European Journal of Neuroscience 18 (2003) 2538-2544
19. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons and erythropoietin prevents in vitro glutamate-induced neurol death. Neuroscience 76 (1997) 105-116
20. Nitsch C., and Klatzo I. Regional patterns of blood brain barrier breakdown during epileptiform seizures induced by various convulsive agents. Journal of the Neurological Sciences 59 (1983) 305-322
21. Paul V., Subramanian E.H., and Rajasekaran K. Pharmacological evidence for a role of γ-aminobutyric acid A receptor mechanism in modulating nitric oxide synthase activity in rat brain. Neurochemistry International 38 (2001) 209-211
22. Rössner N., and Tempel K. Quantitative Bestimmung der Permeabilität der sagenonnten blut-hirnschranke für Evans-Blue (T 1824). Medicina et Pharmacologia Experimentalis 14 (1996) 169-182
23. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., and Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. European Journal of Pharmacology 274 (1995) 73-81
24. Sakanaka M., Wen T.C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 4635-4640
25. Sasaki R., Masuda S., and Nagao M. Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiological Science 16 (2001) 110-113
26. Siren A.L., and Ehrenreich H. Erythropoietin-a novel concept for neuroprotection. European Archives of Psychiatry and Clinical Neuroscience 251 (2001) 179-184
27. Siren A.L., Knerlich F., Poser W., Gleiter C.H., Bruck W., and Ehrenreich H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathology (Berl) 101 (2001) 271-276
28. Stanness K.A., Westrum L.E., Fornaciari E., Mascagni P., Nelson J.A., Stenglein S.G., Myers T., and Janigro D. Morphological and functional characterization of an in vitro blood-brain barrier model. Brain Research 771 (1997) 329-342
29. Utepbergenov D.I., Mertsch K., Sporbert A., Tenz K., Paul M., Haseloff R.F., and Blasig I.E. Nitric oxide protects blood-brain barrier in vitro from hypoxia/reoxygenation-mediated injury. FEBS Letters 424 (1998) 197-201
30. Üzüm G., Diler A.S., and Ziylan Y.Z. Chronic nicotine pretreatment protects the blood-brain barrier against nicotine-induced seizures in the rat. Pharmacological Research 140 (1999) 263-269
31. Valtschanoffet J.G., Weinberg R.J., Kharazia V.N., Nakane M., and Achmidt H.H.H.W. Neurons in rat hippocampus that synthesize nitric oxide. Journal of Comparative Neurology 331 (1993) 11-121
32. Watschinger B., Watzinger U., Templ H., Spona J., Graf H., and Luger A. Effect of recombinant human erythropoietin on anterior pituitary function in patients on chronic hemodialysis. Hormone Research 36 (1991) 22-26
33. Ziylan Y.Z., Lefauconnier J.-M., Bernard G., and Bourre J.-M. Hormonal influence on permeability of blood-brain barrier; effect of an analog of adrenocorticotropic hormone, β1-24 corticotrophin. Neuroscience Letter 151 (1993) 59-63
34. Ziylan Y.Z., Uzum G., Bernard G., Diler A.S., and Bourre J.M. Changes in the permeability of the blood-brain barrier in acute hyperammonemia. Effect of dexamethasone. Molecular and Chemical Neuropathology 20 (1993) 203-218